Severe combined immunodeficiencies

Czech version

Authors: Záveská Dita ^1,2; Pospíšilová Ilona ¹; Bánszka Karin ¹; Freiberger Tomáš ³; Grombiříková Hana ³; Králíčková Pavlína ²
Authors‘ workplace: Dětská klinika, Lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Hradec Králové ¹; Ústav klinické alergologie a imunologie, Lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Hradec Králové ²; Centrum kardiovaskulární a transplantační chirurgie Brno ³
Published in: Čes-slov Pediat 2023; 78 (2): 103-109.
Category:
doi: https://doi.org/10.55095/CSPediatrie2023/015

Overview

Severe Combined Immunodeficiencies (SCID) are a group of childhood diseases with a very serious prognosis. They occur with a frequency of 1 in 40–100,000 children under one year of age. Early diagnosis is the main prognostic factor for the success of therapy. If left untreated, it is fatal. Causal treatment is haematopoietic stem cell transplantation. Since January 2022, a pilot newborns screening project for SCID has been running in the Czech Republic.

This article presents case reports of two patients with SCID diagnosed in our department in 2021. The first is an 8-month-old boy hospitalized for bilateral pneumonia with respiratory insufficiency. Pneumocystis jiroveci was identified as the causative agent. The condition was preceded by a period of failure to thrive and laboratory findings of lymphopenia. Additional immunological examination revealed severe hypogammaglobulinemia with impaired specific antibody production and T lymphopenia with low activation tests. Genetic testing revealed an X-linked form of SCID (defect in the IL2 receptor gene; c.925-13>G). The boy was subsequently successfully transplanted.

Second case report of a 2-month-old girl hospitalized for severe infection with concurrent SARS-CoV-2 positivity with fatal outcome. Post mortem findings were generalized CMV infection, severe thymic dysplasia with absence of T lymphocytes. The cause was determined to be an autosomal recessive form of SCID with mutation of the IL7 receptor gene (biallelic defect NM_002185.5: c.132C >A, p. Ser44Arg, a c.514delG, p. Glu172Lysfs*10).

Keywords:

haematopoietic stem cell transplantation – SCID – early diagnostics – neonatal screening

Sources

1. Smíšek P, Janda A, Mejstříková E, et al. Atypická manifestace těžké vrozené munodeficience. Pediatr Praxi 2012; 13(2): 91–93.

2. Purkartová M, Formánková R, Hrušák O, et al. Severe combined immunodeficiency with atypical phenotype – case report. Čes Slov Pediat 2020; 75: 356–361.

3. Bartůňková J, Šedivá A. Imunodeficience. Praha: Grada 2021.

4. Lebl J, Janda J, Pohunek P, et al. Klinická pediatrie. Praha: Galén 2012.

5. Klocperk A. Závažné buněčné imunodeficience. proLekare.cz. 2018.

6. Klocperk A, Bloomfield M, Šedivá A. Kombinované imunodeficience spojené se syndromickými příznaky. Čes Slov Pediat 2021; 76(4): 194–201.

7. De Francesco MA, Ianiro G, Monini M, et al. Persistent infection with rotavirus vaccine strain in severe combined immunodeficiency (SCID) child: is rotavirus vaccination in SCID children a Janus face? Vaccines 2019; 7: 185.

8. Chapel H. Základy klinické imunologie. Praha: Triton 2018.

9. Kalina T, Bakardjieva M, Blom M, et al. EuroFlow standardized approach to diagnostic immunopheneotyping of severe PID in newborns and young children. Front Immunol 2020; 11: 371.

10. Kohn LA, Kohn DB. Gene therapies for primary immune deficiencies. Front Immunol 2021; 12: 648951.

11. Králíčková P. Primární imunodeficience – diagnostika a léčba. Pediatr Praxi 2021; 22: 26–31.

12. UZIS. Dostupné na: https://nsc.uzis.cz/sma-scid/#tezka-kombinovana- -imunodeficience-SCID

13. Rozsíval P, Pařízková E, Králíčková P. Primární imunodeficity u dětí, současné možnosti léčby. Pediatr Praxi 2012; 13(3): 149–152.

14. EMA. Dostupné na: https://www.ema.europa.eu/en/medicines/human/ EPAR /strimvelis

15. Klocperk A, Sediva A. První transplantace thymu v České republice jako nová terapeutická možnost pro pacienty s kompletním syndromem. Alergie 2019; 2019: 200–205.

16. Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022.